| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |